AM Best Comments on Health Care Service Corporation’s Planned Acquisition of The Cigna Group’s Medicare Business
AM Best Comments on Health Care Service Corporation’s Planned Acquisition of The Cigna Group’s Medicare Business
AM Best has commented that the Credit Ratings (ratings) of Health Care Service Corporation, a Mutual Legal Reserve Company (d/b/a Blue Cross Blue Shield of Illinois/Texas/New Mexico/Oklahoma/Montana) (HCSC) (headquartered in Chicago, IL) and its subsidiaries (see listing below) remain unchanged following its announcement that it has entered into a definitive agreement to acquire all of The Cigna Group’s (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] Medicare Advantage, Medicare Part D, Medicare Supplement and CareAllies businesses.
AM Best anticipates that HCSC will maintain its strongest level of risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), and its overall balance sheet strength. The transaction is projected to have a limited impact on HCSC’s overall balance sheet metrics, and financial leverage is expected to remain within AM Best’s tolerances with interest coverage remaining strong. The transaction is expected to expand HCSC’s geographic diversification with the addition of business outside of HCSC’s core Blue Branded states. Additionally, the additional membership and revenues will aid in providing additional scale and capabilities to HCSC’s Medicare Advantage business.
The transaction is expected to close in the first quarter of 2025, subject to regulatory approval and customary closing conditions. AM Best will continue to closely monitor the transaction and the impact to the HCSC and its subsidiaries.
The ratings of Health Care Service Corporation, a Mutual Legal Reserve Company and its following subsidiaries remain unchanged following the aforementioned announced acquisition agreement:
- Health Care Service Corporation Group
- Dearborn Life Insurance Company
- Dearborn National Life Insurance Company of New York
- GHS Health Maintenance Organization, Inc.
- GHS Insurance Company
- HCSC Insurance Services Company
- Health Care Service Corporation-Texas HMO Line of Business
- Health Care Service Corporation-Illinois HMO Line of Business
This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Jennifer Asamoah
Senior Financial Analyst
+1 908 882 2080
jennifer.asamoah@ambest.com
Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com
Joseph Zazzera
Director
+1 908 882 2442
joseph.zazzera@ambest.com
Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240202937944/en/
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth